Caspase-3, activated, cleaved Asp175

ANTIBODY polyclonal manufacturer Cat# 9661<br />References: <br /><a href="/papers/alpha-synuclein-promotes-snare-complex-assembly-vivo-and-vitro" target="_new">Burré J, 2010</a><br /><a href="/papers/progr

NeuN (A60)

ANTIBODY monoclonal A60 manufacturer Cat# MAB377 <br />References:<br /><a href="/papers/presenilin-1-mutants-impair-self-renewal-and-differentiation-adult-murine-subventricular-zone" target="_new">Veeraraghavalu, 2010</a&g

Calmodulin

ANTIBODY monoclonal manufacturer Cat# 05-173 <br />Reference: <br /><a href="/papers/decoding-nmda-receptor-signaling-identification-genomic-programs-specifying-neuronal-survival" target="_new">Zhang, 2007</a> Immunogen

Kailai Duan

Homburg, Germany

Elias Michaelis

University of Kansas
Lawrence, United States

Research Participants Moderator

United States

Cell Lines Moderator

United States

Collaborators Moderator

United States

PAPER Monte SM, Ghanbari K, Frey WH, Beheshti I, Averback P, Hauser SL, Ghanbari HA, Wands JR

Characterization of the AD7C-NTP cDNA expression in Alzheimer's disease and measurement of a 41-kD protein in cerebrospinal fluid.

J Clin Invest. 1997 Dec 15;100(12):3093-104. PubMed: 9399956

PAPER Verpillat P, Bouley S, Hannequin D, Belliard S, Puel M, Thomas-Anterion C, Dubois B, Agid Y, Campion D, Clerget-Darpoux F, Brice A

Alpha2-macroglobulin gene and Alzheimer's disease: confirmation of association by haplotypes analyses.

Ann Neurol. 2000 Sep;48(3):400-2. PubMed: 10976654

PAPER Kurz A, Riemenschneider M, Buch K, Willoch F, Bartenstein P, Müller U, Guder W

Tau protein in cerebrospinal fluid is significantly increased at the earliest clinical stage of Alzheimer disease.

Alzheimer Dis Assoc Disord. 1998 Dec;12(4):372-7. PubMed: 9876968

PAPER Licastro F, Mallory M, Hansen LA, Masliah E

Increased levels of alpha-1-antichymotrypsin in brains of patients with Alzheimer's disease correlate with activated astrocytes and are affected by APOE 4 genotype.

J Neuroimmunol. 1998 Aug 1;88(1-2):105-10. PubMed: 9688331

PAPER Galasko D, Chang L, Motter R, Clark CM, Kaye J, Knopman D, Thomas R, Kholodenko D, Schenk D, Lieberburg I, Miller B, Green R, Basherad R, Kertiles L, Boss MA, Seubert P

High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype.

Arch Neurol. 1998 Jul;55(7):937-45. PubMed: 9678311

PAPER Angelis P, Scharf S, Mander A, Vajda F, Christophidis N

Serum interleukin-6 and interleukin-6 soluble receptor in Alzheimer's disease.

Neurosci Lett. 1998 Mar 13;244(2):106-8. PubMed: 9572596

PAPER Sáez-Valero J, Sberna G, McLean CA, Masters CL, Small DH

Glycosylation of acetylcholinesterase as diagnostic marker for Alzheimer's disease.

Lancet. 1997 Sep 27;350(9082):929. PubMed: 9314873